Cargando…
Correction of RNA splicing defect in β(654)-thalassemia mice using CRISPR/Cas9 gene-editing technology
β(654)-thalassemia is a prominent Chinese subtype of β-thalassemia, representing 17% of all cases of β-thalassemia in China. The molecular mechanism underlying this subtype involves the IVS-2-654 C→T mutation leading to aberrant β-globin RNA splicing. This results in an additional 73-nucleotide exon...
Autores principales: | Lu, Dan, Gong, Xiuli, Fang, Yudan, Guo, Xinbing, Chen, Yanwen, Yang, Fan, Zhao, Guijun, Ma, Qingwen, Zeng, Yitao, Zeng, Fanyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152980/ https://www.ncbi.nlm.nih.gov/pubmed/34706494 http://dx.doi.org/10.3324/haematol.2020.278238 |
Ejemplares similares
-
Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation
por: Li, Mengjia, et al.
Publicado: (2023) -
Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease
por: Geisness1, Athena C., et al.
Publicado: (2021) -
Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis
por: Lopinto, Julien, et al.
Publicado: (2022) -
Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study
por: Galadanci, Najibah A., et al.
Publicado: (2022) -
Assessment of functional shunting in patients with sickle cell disease
por: Afzali-Hashemi, Liza, et al.
Publicado: (2022)